The imaging of C-CPE binding to the canine tumor cell lines proved that the protein can specifically target CLDN-3, -4, and -7, demonstrating that the functionalization did not alter the binding capacity to CLDN [43]. The gene discussed is CLDN3; the disease is neoplasm.